Atlas Trials

Apixaban Dose Reduction in Patients With Elevated Drug Levels

Clinical trial NCT02809469 · UNKNOWN

Trial details

NCT number
NCT02809469
Sponsor
Hamilton Health Sciences Corporation
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Atrial Fibrillation
Start date
2016-08-01
Primary completion
2018-08-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.